Bayer: break­throughs in health care and nu­tri­tion in­dus­try

Shanghai Daily - - CIIE -

work­ing with the oph­thal­mol­ogy com­mu­nity to pro­vide ed­u­ca­tion around the im­por­tance of eye health and im­prove out­comes for those who are af­fected by vis­ual im­pair­ment or blind­ness.

With a fo­cus on cur­rent ur­gent de­mands in the field of cancer, Bayer in­tro­duced drugs to im­prove qual­ity of life, es­pe­cially in liver cancer treat­ment. Bayer’s cancer drugs have al­ready been ap­proved in China for sev­eral types of cancer, in­clud­ing metastatic col­orec­tal cancer, gas­troin­testi­nal stro­mal tu­mor, ad­vanced thy­roid car­ci­noma and re­nal cell car­ci­noma.

Con­sumer health

Bayer has gath­ered a va­ri­ety of its star prod­ucts, some of which are de­buts on the Chi­nese mar­ket, across its af­fil­i­ates, in­clud­ing Ele­vit vi­ta­min com­plex tablets for preg­nancy im­ported from Aus­tralia, and One A Day vi­ta­min com­plex port­fo­lio from Ger­many. One prod­uct worth high­light­ing is Clar­i­tyne anti-al­lergy syrup for chil­dren. Clar­i­tyne is the orig­i­nal brand for Lo­rata­dine. Clar­i­tyne Syrup for chil­dren dis­played is fully im­ported from Europe, tailor-made for the chil­dren at the age be­tween 2 and 12 to quickly re­lieve mul­ti­ple al­ler­gies.

In the self-care field, 1 dol­lar spent equals a sav­ing of 6-7 dol­lars of health­care in­vest­ment. The annual growth of non-pre­scrip­tive medicine has reached 6%, where we see high growth po­ten­tial in China still. Bayer has been com­mit­ted to self-care with the in­ten­tion to build a healthy life­style. This is also one of the key mes­sages Bayer wants to share with the expo par­tic­i­pants.

Crop sci­ence

This year, by ac­quir­ing Mon­santo, Bayer has en­hanced its global edge in agri­cul­ture. Bayer Crop Sci­ence di­vi­sion has been closely fol­low­ing the long-term trends of the agri­cul­tural mar­ket and pro­mot­ing de­vel­op­ment through seeds & trait tech­nolo­gies, crop pro­tec­tion so­lu­tions and data sci­ence.

In Crop Sci­ence, Bayer will highlight our ef­forts to shape agri­cul­ture through in­no­va­tion for the ben­e­fit of farm­ers, con­sumers and our planet, start­ing from sow­ing, the very be­gin­ning of our food, to man­ag­ing crops, to har­vest­ing, then to con­sum­ing the food. Bayer to­gether not only keeps crops healthy and the har­vest higher in quan­tity and qual­ity, but also helps pre­serve bio­di­ver­sity.

An­i­mal health care

Pets have be­come a key fam­ily mem­bers, giv­ing rise to a high po­ten­tial for Bayer’s pet busi­ness. As a con­se­quence, pop­u­lar pet prod­ucts have surged on the Chi­nese mar­ket.

Bayer’s at­tach­ment to China can track back to 1882; in 1913, Bayer es­tab­lished the 1st Chi­nese branch in Shang­hai; in 1936, Bayer started pro­duc­ing As­pirin in Shang­hai; in 2009, Bayer es­tab­lished global phar­ma­ceu­ti­cals R&D cen­ter in Beijing... After over a cen­tury in China, Bayer’s sales rev­enue last year in China has reached EUR 2.8 bil­lion, with ap­prox­i­mately 10,000 staff span­ning 7 pro­duc­tion bases. Bayer is also plan­ning to es­tab­lish an R&D cen­ter for con­sumer health at Qi­dong, Jiangsu Prov­ince.

Look­ing ahead, Celina said, “When I first came to China in 1993, Shang­hai was a very dif­fer­ent place. There were many op­por­tu­ni­ties. But if you fast for­ward now, twenty-five years later, Shang­hai is a glit­ter­ing city, full of in­no­va­tion and dy­namism, full of prom­ise.”

China is open­ing up its mar­ket to the world with con­fi­dence and has proven to be a great na­tion with self-as­sur­ance and fore­sight em­brac­ing the world and pro­mot­ing global open at­ti­tudes to in­ter­na­tional part­ners. In­dus­tries are vested with more com­pet­i­tive op­por­tu­ni­ties with im­proved tech­nol­ogy.

“China has been, and will con­tinue to be, a key mar­ket for our global busi­ness strat­egy and growth. We be­lieve Bayer con­trib­utes to the de­vel­op­ment of China, and the China In­ter­na­tional Im­port Expo is a great chance for us to bring more high-qual­ity prod­ucts and so­lu­tions to China, to meet the needs of Chi­nese pa­tients, con­sumers and farm­ers and im­prove their lives,” said Celina.

Newspapers in English

Newspapers from China

© PressReader. All rights reserved.